Cynthia Chua, M.D.
Listening to each patient and developing a specialized care plan is what guides the practice of OHC’s Cynthia Chua, M.D. “I listen to my patients and do what is best for each particular patient.”
Dr. Chua is board certified in internal medicine and medical oncology in Ohio, Kentucky, and Indiana. After graduating from medical school at Duke University, she completed a residency at Boston University Hospital and went on to a fellowship at Duke University Medical Center.
Breast cancer, lung cancer, and lymphoma are Dr. Chua’s areas of interest. “Cancer care is an intellectually challenging field that requires a broad base of knowledge and skills,” says Dr. Chua.
When she’s not working, Dr. Chua enjoys cooking…and eating what she cooks.
Cooking and eating
Duke University School of Medicine
University Hospital, Boston
University Hospital, Boston
Duke University Medical Center
CERTIFICATIONS & LICENSURES
American Board of Internal Medicine
American Board of Medical Oncology
National Board of Medical Examiners
American Society of Colposcopy and Cervical Pathology
Academy of Medicine, Cincinnati
Ohio State Medical Association
Bethesda North Pharmacy and Therapeutics
AWARDS & HONORS
Service Award, Bethesda North Hospital
Williamson, KL, Clutter Dr. EMCH R. Alexander M., Burroughs AE, Chua, CC, Bogel ME. Conformational analysis by NMR. Shift reagent studies on acyclic alcohols, 1H and 13C spectra of the six-carbon aliphatic alcohols. J. Amer Chem Soc 1974;96
Hixson SH, Brownie TF, Chua CC, Crapster BB, Satlin LM, Hixson SS, Boyce CO, Ehrich M, Novak EK. Bifunctional aryl azides as probes of the active sites of enzymes. Ann NY Acad Sci 1980; 346:104-114
Chua CC, Hoffman EM, Adams JP, Rosse WF. Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnalhemmoglobinuria. Blood 1980; 55(5)
Chua CC, Coleman RE, Nadler P, Bast RC Jr. Transcient hematologic abnormalities in patients receiving recombinant human tumor necrosis factor Blood 1987; 70(5)
Conklin P, Chua CC, Nadler P, Weinberg JB. Autocrine stimulation of human mononuclear phagocytes by recombinant human tumor necrosis factor in vitro and in vivo: enhanced procoagulant activity and hydrogen peroxide generation. Blood 1987; 70(5) (suppl 1):86a
Chua CC, Wood D, Brophy L, Nadler P, Bast RC Jr. Phase I clinical trial of recombinant human tumor necrosis factor (rHuTNF) given as a daily x5 schedule. Proc Amer Soc Clin Onc 1988
Chua CC, Greenberg ML, Viau A, Nucci M, Brenchman WD Jr., Hershfield MS. Use of polythylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin’s lymphoma. Ann Int Med 1988; 109: 114-117
Conklin P, Chua CC, Haney A, Greenberg C, Weinberg JB. Clinical trial of recombinant human tumor necrosis factor: in vivo and in vitro stimulation or mononuclear cell phagocytic function. Cancer Res 1988; Oct 1, Vol 48; Issue 19. 5604-5609
Hart L, Chua CC, Brophy L. Salvage Chemotherapy for Metastatic Breast Carcinoma Using Cisplatinum, Fluorouracil and Leucovorin. Proc Amer Soc Clinic Onc 1989, 8:43
Treon, SP et al. Thalidomide and Rituximab in Waldenstÿom’s Marcroglobulinemia. Blood 2008; 112:4452.7
As a member of our OHC physician team, Dr. Chua has full access to the OHC Clinical Trial research program.
We encourage our patients to discuss all of their healthcare options — including Clinical Trial research programs — with their doctor.
The following are recent reviews provided by actual OHC patients:
"Dr. Chua does a great job of explaining things to me. I feel that she uses the most current information and tailors it to my individual circumstances. She listens to what I have to say and takes it into consideration."
"I have a lot of trust in Dr. Chua. I would and have trusted her with my life. She always makes the decisions which are best for my health."
"I have been with Dr. Chua since 1990. She is an awesome doctor and person. I would recommend her to everyone. Thanks for being with me all these years. You kept me alive."